Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023
Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Aducanumab: What About the Patient?
Ann Neurol 90:334-335, Petersen, R.C., 2021
"Noncognitive" Symptoms of Early Alzheimer Disease
Neurol 84:617-622, Masters, M.C.,et al, 2015
Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015
Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014
Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005
Age-Related Memory Decline
Arch Neurol 58:360-364, Small,S.A., 2001
Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999
Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations
Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995
Extrapyramidalism in Alzheimer's Disease:Prevalence, Psychiatric and Neuropsychological Correlates
JNNP 57:1503-1509, Merello,M.,et al, 1994
Differential Diagnosis in Dementia, Principal Components Analysis of Clinical Data From a Population Survey
Arch Neurol 50:72-77, Jorm,A.F.,et al, 1993
Cortical Biopsy in Alzheimer's Disease:Dx Accuracy & Neurochem Neuropath, & Cognit Correl
Ann Neurol 32:625-632, Dekosky,S.T.,et al, 1992
Clonidine Treatment of Alzheimer's Disease
Arch Neurol 46:376-378, Mohr,E.,et al, 1989
Possible Biochemical Basis of Memory Disorder in Alzheimer Disease
Ann Neurol 3:471, Smith,C.M.,et al, 1978